Shopping Cart
- Remove All
- Your shopping cart is currently empty
KM-023 is a new second-generation non-nucleoside reverse transcriptase inhibitor for the study of human immunodeficiency virus (HIV) type 1 infection.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $153 | In Stock | |
5 mg | $380 | In Stock | |
10 mg | $570 | In Stock | |
25 mg | $916 | In Stock | |
50 mg | $1,250 | In Stock | |
100 mg | $1,680 | In Stock | |
500 mg | $3,370 | In Stock | |
1 mL x 10 mM (in DMSO) | $377 | In Stock |
Description | KM-023 is a new second-generation non-nucleoside reverse transcriptase inhibitor for the study of human immunodeficiency virus (HIV) type 1 infection. |
In vivo | KM-023 demonstrated dose- and time-dependent nonlinear pharmacokinetic characteristics after single or multiple doses over a dose range (75-600 mg) in healthy subjects. KM-023 showed a 0.6-fold accumulation after multiple doses in the 600 mg dose group. The mean half-life values ranged between 20.7 and 31.2 hours. KM-023 was generally well tolerated without serious adverse events. KM-023 showed favorable tolerability in this study.[1] |
Molecular Weight | 325.36 |
Formula | C18H19N3O3 |
Cas No. | 1097628-00-6 |
Smiles | C(=O)(C1=C(C(C)C)C(=O)NC(=O)N1CC)C2=CC(C#N)=CC(C)=C2 |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 11 mg/mL (33.81 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.